Iodine Software Launches Appeals Management Workspace Supporting Denials Management, Alongside GenAI Platform Enhancements
AUSTIN, Texas–(BUSINESS WIRE)– Iodine Software, a leader in healthcare AI and pioneer in mid-revenue cycle optimization, today launches its Appeals Management Workspace within its AwareUM solution. This upgrade revolutionizes concurrent pre-claim denials management through automated appeal letter generation, centralized denial tracking, and intuitive customizable nurse-physician collaboration tools. The expansion of these tools builds on the momentum of an incredibly successful rollout of Iodine Software’s existing Generative AI (GenAI) tools, AwareCDI and AwareUM; Users report dramatic efficiency gains, with time spent on initial reviews reducing by 63 percent from an average of fifteen minutes to as little as five minutes to complete. The new Appeals Management Workspace will continue leveraging this technology to further solve problems in the pre-claim denials management space, remedying inefficient processes and scaling clinical intelligence in the revenue cycle.
Claims denials are steadily rising across the healthcare sector, making revenue collection more complicated and increasing administrative burden and financial strain as healthcare organizations must allocate more resources to appealing and resubmitting claims. According to a 2024 survey from Premier, over half (54.3 percent) of denials were ultimately overturned and the claims paid, but only after multiple, costly and time-consuming rounds of provider appeals. These inefficiencies cause distress to patients and health systems alike – especially crucial clinical staff like utilization management teams – and mounting issues like staffing shortages, missed revenue opportunities, and pressure to increase quality metrics have created an urgency for innovative solutions.
Iodine Software has spent more than a decade building advanced technology to optimize clinical documentation, ensuring integrity and a holistic clinical snapshot of patient care, benefiting multiple entities within the healthcare ecosystem. The company’s latest innovation across the portfolio includes:
- Condition & Update Summaries: Reduce review and re-review times by leveraging automated GenAI summaries of conditions and new patient record activity. Simplify and increase efficiency within Clinical Documentation Integrity (CDI) reviews.
- Appeals Management: Offer real-time insights for tracking and logging denials and automated GenAI appeals letters. Identify high-priority cases and highlight top-level information to facilitate more efficient nurse review.
- CDI-UM Collaboration: Improve communication between UM and CDI nurses, and physicians to better establish medical necessity and comprehensive documentation. Expedite the process of curating information across the patient journey.
These new capabilities leverage the power of Generative AI to transform how healthcare organizations manage complex documentation review, appeals management, and denial prevention, delivering measurable improvements in workflow efficiency and revenue cycle operations.
“Healthcare organizations are facing an increasingly complex landscape of claims denials, creating significant administrative and financial burdens”
“Healthcare organizations are facing an increasingly complex landscape of claims denials, creating significant administrative and financial burdens,” said William Chan, CEO and Co-Founder of Iodine Software. “With our new Appeals Management Workspace and GenAI-powered enhancements, we are tackling administrative waste across the revenue cycle, providing automation to streamline denials management, improve collaboration, and accelerate revenue recovery. Our commitment remains steadfast: to empower healthcare teams by scaling clinical intelligence to predict next steps, automate processes, and reduce administrative toil, driving greater efficiency, accuracy, and financial stability across the revenue cycle.”
Today’s announcement builds on the news that Iodine Software helped clients achieve a total reimbursement impact of $2.394B in 2024. AwareCDI delivered an impressive 11x average ROI, while AwareUM drove a 16% Obs-to-IP conversion rate impact with a medical necessity denial rate of just 2%—well below the industry average of 5-6%.
About Iodine:
Iodine has been the leader in AI-powered solutions for over a decade, delivering proven ROI by automating mid-cycle revenue operations. Our Clinical Intelligence Engine, built on the largest set of clinical data in the industry, provides real-time insights to predict outcomes, automate complex processes, and reduce administrative toil in the revenue cycle.
By continuously reviewing every chart, our platform creates the most accurate clinical picture, bridging the gap between manual processes and clinical intelligence. This scalable clinical intelligence enables healthcare organizations to capture the full value of patient care and allows teams to focus on what matters most.
Recognized as Best in KLAS, Iodine’s Clinical Intelligence Suite scales clinical intelligence through solutions like AwareCDI, AwareUM, and AwareAudit, helping healthcare organizations achieve financial returns and improve quality. Learn more at www.iodinesoftware.com.
Media Contact
Press Contact:
SolComms
Iodine@solcomms.co